<unk>  (trade name Arlansa, codenamed SCH 900518), is an inhibitor of NS3/4A serine protease, intended for the treatment of chronic hepatitis C caused by genotype 1 virus in combination with other antiviral drugs.<unk>  is the first Russian tableted medication for the treatment of chronic hepatitis C.
Narlaprevir
Simeprevir
Glecaprevir
Telaprevir
Saquinavir
Grazoprevir
Fostemsavir
Abacavir